PUBLISHER: The Business Research Company | PRODUCT CODE: 1387854
PUBLISHER: The Business Research Company | PRODUCT CODE: 1387854
“Digestive Enzymes Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on digestive enzymes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for digestive enzymes? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The digestive enzymes market global report ” from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Digestive enzymes are substances that play a crucial role in the digestive process by facilitating the breakdown of food. These proteins expedite the chemical reactions necessary to convert food into compounds that can be absorbed by the digestive system. They are produced and released by various glands and cells in the body, including the salivary glands, the stomach lining, the pancreas, and the small intestine.
The primary categories of digestive enzymes include those involved in carbohydrate digestion, protease enzymes that assist in breaking down proteins, lipase enzymes that aid in the digestion of fats, and various other enzyme types. Lipase, for example, is a protein generated by the pancreas, a small organ situated near the stomach, and it specifically supports the digestion of dietary fats. Digestive enzymes can be derived from various sources, including animals, fungi, microorganisms, and plants, and they find applications in treating conditions such as indigestion, chronic pancreatitis, irritable bowel syndrome, and other digestive disorders. These products are typically available through different distribution channels, including retail stores and online outlets.
The digestive enzymes market research report is one of a series of new reports from The Business Research Company that provides digestive enzymes market statistics, including digestive enzymes industry global market size, regional shares, competitors with a digestive enzymes market share, detailed digestive enzymes market segments, market trends and opportunities, and any further data you may need to thrive in the digestive enzymes industry. These digestive enzymes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The digestive enzymes market size has grown rapidly in recent years. It will grow from $0.99 billion in 2023 to $1.1 billion in 2024 at a compound annual growth rate (CAGR) of 10.8%. The growth observed in the historical period can be attributed to several factors, including the increasing awareness of digestive health, shifts in dietary habits, an aging population, a rising incidence of gastrointestinal disorders, the expansion of the nutraceutical industry, ongoing research and development efforts, and the growth of e-commerce in the distribution of digestive health products.
The digestive enzymes market size is expected to see rapid growth in the next few years. It will grow to $1.73 billion in 2028 at a compound annual growth rate (CAGR) of 12.0%. The anticipated growth in the forecast period can be attributed to factors such as health-conscious consumers, the integration of digestive health into mainstream healthcare, and the increasing popularity of plant-based and natural products. Significant trends expected during this forecast period include innovative advancements in enzyme formulations, the development of customized enzyme formulations to cater to individual needs, the emphasis on clean labels and the use of natural ingredients, the growth of personalized nutrition and testing services, and continued research and innovation in the field of digestive health.
The growing prevalence of gastrointestinal disorders across various age groups is a significant factor propelling the expansion of the digestive enzymes market. These disorders encompass a wide range of issues in the gastrointestinal tract, from the mouth to the anus, often resulting from an insufficient supply of digestive enzymes. To manage these conditions, individuals often need to orally consume digestive enzymes in the form of dietary supplements or medications. The surge in gastrointestinal disorders can be attributed to factors such as smoking, dietary choices, genetic predisposition, hygiene practices, increased antibiotic use, and the effects of industrialization and urbanization on the environment. According to a survey by the American Gastroenterological Association in September 2022, approximately 60-70 million Americans are grappling with gastrointestinal diseases that can significantly disrupt their daily lives. The data also reveals that nearly 40% of Americans had to curtail their routine activities in the past year due to uncomfortable bowel symptoms, with a higher prevalence of functional gastrointestinal disorders (FGID) among women. This issue is not limited to the United States, as a large-scale multinational study found that over 40% of the global population is affected by FGIDs. Consequently, the rising incidence of digestive diseases is a key driver of growth in the digestive enzymes market.
The escalation of unhealthy lifestyles is another factor contributing to the expansion of the digestive enzymes market. Unhealthy habits, including poor dietary choices, lack of physical activity, excessive alcohol consumption, smoking, and inadequate sleep, elevate the risk of chronic diseases and overall health deterioration. Digestive enzymes play a crucial role in mitigating the adverse effects of an unhealthy lifestyle by improving digestion and nutrient absorption, thereby promoting digestive health. For instance, a report from The BMC Public Health in September 2021 highlighted that non-communicable diseases (NCDs) are the primary causes of health-related issues worldwide, responsible for 91% of deaths and nearly 87% of disability-adjusted life years (DALYs) in Europe, partly due to unhealthy diets and lifestyles. Consequently, the increasing prevalence of unhealthy lifestyles is a driving force behind the growth of the digestive enzymes market.
The use of digestive enzyme supplements and drugs can have potential side effects, which act as a hindrance to the market's growth. Prolonged and excessive consumption of digestive enzymes can lead to dependency, resulting in a weakened digestive system. This can manifest as digestive distress, gas, nausea, bloating, reduced stomach acid, and allergic reactions, often accompanied by diarrhea and vomiting. For example, the digestive enzyme bromelain is known to thin the blood, increasing the risk of excessive bleeding due to its anti-platelet activity. Consequently, the side effects associated with excessive and continuous consumption of digestive enzymes have a negative impact on the market's growth.
To address the diverse needs of consumers, companies in the digestive enzymes market are actively investing in the development of tailored digestive enzymes. These condition-specific enzymes are designed to support the digestion of individuals with specific sensitivities and may contain a combination of enzymes in a single product. For instance, Sabinsa, a U.S.-based provider of herbal extracts, cosmeceuticals, minerals, and dietary supplements, has formulated DigeZyme, a multi-enzyme complex comprising five different enzymes-cellulase, lactase, amylase, lipase, and protease. This product is widely used by individuals who struggle to digest carbohydrates, fats, and proteins. The emphasis on creating customized digestive enzymes is on the rise within the industry.
Companies in the digestive enzymes market are placing a strong focus on developing natural and plant-based digestive enzyme supplements. These products offer gentle digestive support, enhance nutrient absorption, and alleviate digestive discomfort. They contribute to overall gut health and are easily absorbed by the body. For instance, in January 2021, Wellbeing Nutrition, an India-based organic plant-based nutrition company, launched a plant-based Probiotic + Prebiotic product that promotes optimal gut bacteria responsible for intestinal well-being. This product aids in healthy digestion, detoxification, acidity reduction, the treatment of Irritable Bowel Syndrome (IBS) and constipation, improved metabolism, and enhanced immune function. The industry is witnessing increased investments in the development of natural and plant-based digestive enzymes.
In June 2021, BioGaia, a Swedish probiotic brand, acquired MetaboGen for an undisclosed sum. This acquisition aims to expedite the development of new probiotic strains, particularly strict anaerobic bacteria that are part of BioGaia's pipeline. MetaboGen is a Swedish biotechnology company specializing in the production of digestive enzymes.
Major companies operating in the digestive enzymes market include Garden of Life LLC, Biotics Research Corporation, Klaire Laboratories, Abbott Nutrition, AbbVie Inc., Johnson & Johnson Inc., Amway Corporation, Food State Inc., Matsun Nutrition, Metagenics Inc., Twinlab Corporation, AST Enzymes, Vemo Corp., Advanced Vital Enzymes Pvt. Ltd., Zeus Biotech Limited, Vox Nutrition Inc., Enzyme Bioscience Pvt. Ltd., XYMOGEN Inc., Douglas Laboratories, Thorne Research Inc., Integrative Therapeutics LLC, Pure Encapsulations Inc., Ortho Molecular Products Inc., Designs for Health Inc., Master Supplements Inc., Proteozymes Pvt Ltd., Chr. Hansen Holding A/S, Danone S.A., DSM Nutritional Products AG, DuPont de Nemours Inc., Kerry Group plc, Koninklijke DSM N.V., Lonza Group AG, Nestle S.A., Pfizer Inc., Sanofi S.A., Specialty Enzymes & Biotechnologies Co., Thermo Fisher Scientific Inc., Wacker Chemie AG
North America was the largest region in the digestive enzymes market in 2023. Middle East is expected to be the largest growing region in the digestive enzymes market report during the forecast period. The regions covered in the digestive enzymes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the digestive enzymes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada
The digestive enzymes market consists of sales of amylase, maltase, and lactase. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.